Current Issue

Top Keywords

Subscribe today to our complimentary e-Newsletters and stay abreast of the latest biotech news and trends.

THIS KEYWORD IS SPONSORED BY:

Corporate Profiles: Targeting Unmet Needs in Oncology
MolMed Exploits a Tumor-Homing Peptide and a Herpes Gene to Fight Cancer
Feature Articles: Immune Response Markers for Cancer Vaccines
Researchers Find It’s All about T Cells
Feature Articles: Biomarker Analysis Makes Strides
Feature Articles: Tapping the Expertise of Oncology CROs
Corporate Profiles: Profiling Platform Delves Into Tumors
Caris' Molecular-Level Services Focus on Finding the Most Effective Cancer Therapies

Immune Response Markers for Cancer Vaccines Paint a Clearer Picture
February 28, 2012
In trying to understand what constitutes an effective immune response, researchers find it’s all about T cells.
How Provenge Laid the Groundwork for Developing and Regulating Cancer Vaccines
February 27, 2012
FDA’s recently issued guidelines pull from more than 20 years of research and clinical experience.
Avastin Label Changes Reignites Debate: Is OS or PFS the Better Regulatory Endpoint?
December 13, 2011
A recent panel discussion set the stage for defining standards for drug approval as separate from those for treatment decisions.
Vaccine Isotype Seems to Affect Clinical Outcome in Blood Cancer Trials
December 12, 2011
New results presented at ASH will impact production of autologous immunotherapies.
Personalized Medicine Initiatives Step Into the Cloud to Speed Up R&D
November 21, 2011
Drug developers see advantages in handling and interpreting data generated by large-scale next-gen sequencing.

Tissue-Engineered Tumor Models
Marylou Ingram, M.D., Senior Research Scientist, and Director, In Vitro Systems/Tissue Engineering, Huntington Medical Research Institutes, Pasadena, CA
Stapled Peptides Making Progress
Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics
Protecting the Body’s Tissues After DNA Damage
Michael B. Kastan, M.D., Ph.D., Director, Comprehensive Cancer Center, St. Jude Children’s Research Hospital, Memphis, TN
PROTEIN IMPORTANT IN DIABETES FOUND TO PLAY ROLE IN OTHER DISEASES
Struan Grant, Ph.D., is Associate Director of the Center for Applied Genomics at the Children’s Hospital of Philadelphia and Assistant Professor of Pediatrics, Department of Pediatrics, University of Pennsylvania School of Medicine
NOVEL RETRIEVAL METHOD FOR STUDYING CANCER PROTEINS
Interview with W. Andy Tao, Ph.D., Assistant Professor, Analytical Chemistry and Chemical Biology, Purdue University

	Ambry Genetics Array for Cancer Studies The CancerArray™ is a high-resolution exon-focused 180K array offering genome-wide probe coverage with higher probe density coverage in over 400 known cancer-associated genes. The array enhances the resolution in these cancer regions. The Canc
	Horizon Discovery MDx Reference Standards This suite of genetically defined FFPE cell line standards contains defined stoichiometric ratios of the seven variants of the K-Ras oncogene, for which testing is required to determine individual drug treatment regimens for colorectal cancer patien
	AnaSpec TACE Assay Kit The SensoLyte® 520 TACE (tumor necrosis factor alpha converting enzyme) assay kit offers fluorescence detection at long wavelengths. This kit shows less autofluorescence interference from test compounds and cellular components, and helps provide
	PerkinElmer Imaging Agent The HER2Sense™ fluorescent, discovery-research imaging agent is an antibody-based optical probe for research applications. It is based on trastuzumab, a therapeutic antibody supplied by Roche Custom Biotech used to detect the HER2/Neu receptor

Oncology Biomarkers Congress
2012 October 10 - October 11 Manchester, , UNITED KINGDOM

GEN MAGAZINE
	Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. Subscribe

e-NEWSLETTERS
Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
GEN Daily News Highlights - provides succinct and timely biotech news on the entire biotech field. GEN News Highlights of the Week - showcases the week's top biotech news. GEN Table of Contents (TOC) Alert - This alert provides a sneak peak at the latest issue of GEN. GEN Tech Focus - is published monthly to provide the latest advances in biotech's hottest topics. GEN Biotech Events - a weekly newsletter featuring webinars, meetings, and conferences. GEN New Products Watch - a monthly summary of products and services by tool providers. New product information and special offers from select biotech suppliers.
	All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format


	Sign Up